Preparation of inhalable salbutamol sulphate using reactive high gravity controlled precipitation

Journal of Pharmaceutical Sciences

Volumn 97, Issue 2, 2008, Pages 944-949

  Hu, Tingting ^a,b   Chiou, Herbert ^a   Chan, Hak Kim ^a   Chen, Jian Feng ^b   Yun, Jimmy ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

^c NanoMaterials Technology Pte Ltd   (Singapore)

Author keywords

Dry powder aerosols; High gravity controlled precipitation; Nanoparticles; Powder technology; Pulmonary drug delivery; Rotating packed bed; Salbutamol sulphate

Indexed keywords

SALBUTAMOL SULFATE; SULFURIC ACID;

AQUEOUS SOLUTION; ARTICLE; CHEMICAL REACTION; DRUG SYNTHESIS; DRY POWDER; GRAVITY; PHYSICAL CHEMISTRY; PRECIPITATION; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; THERMOGRAVIMETRY; WATER VAPOR; X RAY POWDER DIFFRACTION;

EID: 39749100131     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21026     Document Type: Article

References (13)

1. Brodka-Pfeiffer K, Langguth P, Grass P, Hausler H. 2003. Influence of mechanical activation on the physical stability of salbutamol sulphate. Eur J Pharmaceut Biopharmaceut 56:393-400.
2. Müller RH, Möschwitzer J, Bushrab FN. 2006. Manufacturing of nanoparticles. In: Gupta RB, Kompella UB, editors. Drugs and the pharmaceutical sciences, Volume 159, 1st edition. New York: Taylor & Francis Group. pp 21-51.
3. Chen JF, Wang YH, Guo F, Wang XM, Zheng C. 2000. Synthesis of nanoparticles with novel technology: High-gravity reactive precipitation. Ind Eng Chem Res 39:948-954.
4. Chen J-F, Zhou M-Y, Shao L, Wang Y-Y, Yun J, Chew NYK, Chan H-K. 2004. Feasibility of preparing nanodrugs by high-gravity reactive precipitation. Int J Pharmaceut 269:267-274.
5. Date AA, Patravale VB. 2004. Current strategies for engineering drug nanoparticles. Curr Opin Coll Interf Sci 9:222-235.
6. Chiou H, Li L, Hu T, Chan H-K, Chen J-F, Yun J. 2007. Production of salbutamol sulfate for inhalation by high-gravity controlled antisolvent precipitation. Int J Pharmaceut 331:93-98.
7. Gonda I. 2004. Targeting by deposition. In: Hickey A, editor. Drugs and the pharmaceutical sciences, Volume 134, 2nd edition. New York: Marcel Dekker. pp 65-88.
8. Louey MD, Razia S, Stewart PJ. 2003. Influence of physico-chemical carrier properties on the in vitro aerosol deposition from interactive mixtures. Int J Pharmaceut 252:87-98.
9. Chawla A, Taylor KMG, Newton JM, Johnson MCR. 1994. Production of spray-dried salbutamol sulfate for use in dry powder aerosol formulation. Int J Pharmaceut 108:233-240.
10. Columbano A, Buckton G, Wikeley P. 2002. A study of the crystallisation of amorphous salbutamol sulphate using water vapour sorption and near infrared spectroscopy. Int J Pharmaceut 237:171-178.
11. Chew NYK, Tang P, Chan H-K, Raper JA. 2005. How much particle surface corrugation is sufficient to improve aerosol performance of powders? Pharmaceut Res 22:148-152.
12. Chan H-K. 2006. Dry powder aerosol drug delivery-Opportunities for colloid and surface scientists. Coll Surf A: Physicochem Eng Aspects 284-285:50-55.
13. Coates MS, Chan H-K, Fletcher DF, Raper JA. 2005. Influence of air flow on the performance of a dry powder inhaler using computational and experimental analyses. Pharmaceut Res 22:1445-1453.